Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
- PMID: 29520346
- PMCID: PMC5842084
- DOI: 10.4174/astr.2018.94.3.129
Early disseminated recurrence after liver resection in solitary hepatocellular carcinoma
Abstract
Purpose: Although few hepatectomy patients develop unexpected early diffuse and multinodular recurrence in the remnant liver, the prognosis in such cases is often dismal. The aim of this study was to evaluate the risk factors of early disseminated multinodular hepatocellular carcinoma (HCC) recurrence within 3 months after liver resection for solitary HCC.
Methods: Eighty-four patients who were diagnosed with recurrent HCC within 3 months after hepatectomy for solitary HCC were retrospectively reviewed. Disseminated HCC recurrence was defined as more than 10 tumors in both lobes and total tumor size >10 cm.
Results: Preoperative α-FP level, incidence of poor tumor grade, and presence of portal vein tumor thrombosis were higher in the patients with disseminated HCC recurrence than in those without disseminated HCC recurrence (P < 0.05). Multivariate analysis showed that α-FP >1,000 ng/dL was a predisposing factor of disseminated HCC recurrence within 3 months after liver resection. The overall survival rate for patients without disseminated HCC recurrence was higher than that for patients with disseminated HCC recurrence (P < 0.001).
Conclusion: Early disseminated multinodular HCC recurrence in hepatectomy patients was associated with preoperative α-FP >1,000 ng/dL. Such patients should be frequently evaluated for the early detection of recurrent HCC for early intervention.
Keywords: Hepatectomy; Hepatocellular carcinoma; Recurrence; Survival; Tumor biomarker.
Conflict of interest statement
CONFLICTS OF INTEREST: No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Characteristics of Early Recurrence After Curative Liver Resection for Solitary Hepatocellular Carcinoma.J Gastrointest Surg. 2019 Feb;23(2):304-311. doi: 10.1007/s11605-018-3927-2. Epub 2018 Sep 13. J Gastrointest Surg. 2019. PMID: 30215196
-
Predicting Hepatocellular Carcinoma Recurrence Beyond Milan Criteria After Liver Resection for Solitary Hepatocellular Carcinoma.J Gastrointest Surg. 2020 Oct;24(10):2219-2227. doi: 10.1007/s11605-019-04363-1. Epub 2019 Sep 3. J Gastrointest Surg. 2020. PMID: 31482410
-
Novel Models Predict Postsurgical Recurrence and Overall Survival for Patients with Hepatitis B Virus-Related Solitary Hepatocellular Carcinoma ≤10 cm and Without Portal Venous Tumor Thrombus.Oncologist. 2020 Oct;25(10):e1552-e1561. doi: 10.1634/theoncologist.2019-0766. Epub 2020 Aug 6. Oncologist. 2020. PMID: 32663354 Free PMC article.
-
Repeat hepatectomy versus microwave ablation for solitary and small (≤3 cm) recurrent hepatocellular carcinoma with early or late recurrence: A propensity score matched study.Eur J Surg Oncol. 2023 May;49(5):1001-1008. doi: 10.1016/j.ejso.2022.12.016. Epub 2022 Dec 26. Eur J Surg Oncol. 2023. PMID: 36585301
-
Above 5 cm, size does not matter anymore in patients with hepatocellular carcinoma.World J Surg. 2014 Nov;38(11):2910-8. doi: 10.1007/s00268-014-2704-y. World J Surg. 2014. PMID: 25099682
Cited by
-
Oncological outcomes of anatomic versus non-anatomic resections for small hepatocellular carcinoma: systematic review and meta-analysis of propensity-score matched studies.World J Surg Oncol. 2022 Sep 19;20(1):299. doi: 10.1186/s12957-022-02770-4. World J Surg Oncol. 2022. PMID: 36117165 Free PMC article.
-
Prognostic significance of early and multiple recurrences after curative resection for hepatocellular carcinoma.BMC Surg. 2024 Oct 29;24(1):339. doi: 10.1186/s12893-024-02642-6. BMC Surg. 2024. PMID: 39468556 Free PMC article.
-
Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study.Ann Hepatobiliary Pancreat Surg. 2021 May 31;25(2):206-214. doi: 10.14701/ahbps.2021.25.2.206. Ann Hepatobiliary Pancreat Surg. 2021. PMID: 34053923 Free PMC article.
-
Operation start time and long-term outcome of hepatocellular carcinoma after curative hepatic resection.Ann Surg Treat Res. 2020 Jul;99(1):1-7. doi: 10.4174/astr.2020.99.1.1. Epub 2020 Jun 29. Ann Surg Treat Res. 2020. PMID: 32676476 Free PMC article.
-
Diffuse Recurrence of Hepatocellular Carcinoma After Liver Resection: Transarterial Chemoembolization (TACE) Combined With Sorafenib Versus TACE Monotherapy.Front Oncol. 2020 Dec 17;10:574668. doi: 10.3389/fonc.2020.574668. eCollection 2020. Front Oncol. 2020. PMID: 33425729 Free PMC article.
References
-
- Cherqui D, Laurent A, Mocellin N, Tayar C, Luciani A, Van Nhieu JT, et al. Liver resection for transplantable hepatocellular carcinoma: long-term survival and role of secondary liver transplantation. Ann Surg. 2009;250:738–746. - PubMed
-
- Lee HY, Rhim H, Lee MW, Kim YS, Choi D, Park MJ, et al. Early diffuse recurrence of hepatocellular carcinoma after percutaneous radiofrequency ablation: analysis of risk factors. Eur Radiol. 2013;23:190–197. - PubMed
-
- Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, et al. Outcomes after curative hepatectomy in patients with non-B non-C hepatocellular carcinoma and hepatitis B virus hepatocellular carcinoma from non-cirrhotic liver. J Surg Oncol. 2014;110:976–981. - PubMed
-
- Kim JM, Kwon CH, Joh JW, Park JB, Lee JH, Kim SJ, et al. Differences between hepatocellular carcinoma and hepatitis B virus infection in patients with and without cirrhosis. Ann Surg Oncol. 2014;21:458–465. - PubMed
-
- Imamura H, Matsuyama Y, Tanaka E, Ohkubo T, Hasegawa K, Miyagawa S, et al. Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol. 2003;38:200–207. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources